To help us deliver the best content to our users, please could you take a moment to answer a few questions? This information is anonymous and for use solely by Hedgehogs.net.
Take surveyNot now
News: Kyle Bass eviscerates a drug company's criticism of his short-selling its stock
46 days ago - Hedge Funds
Texas hedge fund manager J. Kyle Bass, the founder of Hayman Capital Management, has been waging a war against the US pharmaceutical industry and what he has called its "BS pa...
News: Indian pharma's struggle to tighten standards paves way for M&A deals
101 days ago - Reuters: Top News
MUMBAI (Reuters) - India's smaller generic drugmakers, struggling to cope with a bruised reputation and tougher regulation in the United States, are under pressure to consider...
101 days ago - Reuters: Business News
News: Endo Boosts Generics Business With $8 Billion Deal
131 days ago - Dow Jones DBR High Yield Alert
Endo International PLC agreed to buy Par Pharmaceutical Holdings Inc. from private-equity firm TPG for about $8 billion in cash and stock, giving Dublin-based Endo access to p...
News: Teva Bids for Mylan, Seeking to Create Biggest Generics Firm
161 days ago - WSJ.com: What's News Asia
Teva Pharmaceutical has proposed to acquire rival Mylan for about $40 billion, a tie-up that would create the world’s biggest generic drug company by sales.
News: Traders Bet On New Highs In Teva Pharmaceutical
210 days ago - TraderPlanet.com :: Commentaries
Teva Pharmaceutical Industries is the $55B Israeli based, generic drug maker of products such as Azilect and Copaxone. Recently, the company announced it was selling ANDA to A...
News: UPDATE 3-Actavis to take Allergan name, reflecting brand-drug focus
232 days ago - Reuters: Mergers News
NEW YORK, Feb 18 (Reuters) - Actavis Plc, a generic drugmaker that has been steadily acquiring branded medicines, said it will change its name to Allergan Inc after it complet...
News: Ipca hit by FDA ban over Ratlam plant production violations
257 days ago - Reuters: Money News
MUMBAI (Reuters) - U.S. regulator the Food and Drug Administration has banned imports from a Madhya Pradesh manufacturing plant of generic drugmaker Ipca Laboratories Ltd, cit...
News: Ranbaxy to pay $40 million to settle Texas litigation
357 days ago - Reuters: Money News
MUMBAI (Reuters) - Generic drugmaker Ranbaxy Laboratories Ltd said it has agreed to pay $39.75 million to settle litigation concerning its participation in Texas Medicaid, the...
News: Modi must resist U.S. pressure on drug patents - MSF
373 days ago - Reuters: Money News
NEW DELHI (Thomson Reuters Foundation) - Prime Minister Narendra Modi must not give in to U.S. pressure to change intellectual property laws which allow India to produce gener...
© Copyright Hedgehogs.net Limited, 2010